|
Volumn 51, Issue 9, 2001, Pages 726-732
|
Safety profile of almotriptan, a new antimigraine agent: Effects on central nervous system, renal function and respiratory dynamics
a a a a
a
Research Center
*
(Spain)
|
Author keywords
Almotriptan, dog, guinea pig, mouse, rat, safety profile; Antimigraine agent; CAS 154323 57 6
|
Indexed keywords
5 CARBAMOYLTRYPTAMINE;
ALMOTRIPTAN;
ANPIRTOLINE;
ANTIMIGRAINE AGENT;
APOMORPHINE;
CAFFEINE;
DIAZEPAM;
DOMPERIDONE;
FUROSEMIDE;
HEXOBARBITAL;
NARATRIPTAN;
SEROTONIN 1B AGONIST;
SEROTONIN 1D AGONIST;
SUMATRIPTAN;
ANIMAL EXPERIMENT;
ANTIEMETIC ACTIVITY;
ARTICLE;
BLOOD BRAIN BARRIER;
BREATHING MECHANICS;
CENTRAL NERVOUS SYSTEM;
CONTROLLED STUDY;
DIURESIS;
DOG;
DRUG EFFECT;
DRUG EFFICACY;
DRUG PENETRATION;
DRUG SAFETY;
FEMALE;
GUINEA PIG;
HYPOTHERMIA;
KIDNEY FUNCTION;
LOCOMOTION;
MALE;
MOUSE;
NONHUMAN;
RAT;
SLEEP;
SURVIVAL;
|
EID: 0034821816
PISSN: 00044172
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0031-1300106 Document Type: Article |
Times cited : (9)
|
References (24)
|